RECRUITING

Telehealth Intervention for Autism Spectrum Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Autism Spectrum Disorder (ASD) is one of the most frequently occurring childhood-onset neurodevelopmental disorders affecting 1 in every 54 children. Most children with ASD experience challenges participating in daily activities (e.g.: eating, sleeping, bathing, grooming, playing, etc.) and receive occupational therapy intervention to address these. The COVID-19 pandemic has restricted in-person therapy for many of these children and there is an urgent need for evidence-based, validated telehealth intervention. This project will adapt an evidence-based occupational therapy intervention, termed OT4ASD to a telehealth delivery model. The aims of the project are to: 1) adapt the existing intervention protocol to a telehealth delivery model, 2) train therapists and evaluate the therapist's ability to conduct OT4ASD, 3) determine if OT4ASD delivered via the telehealth is acceptable and feasible to parents and interventionists; and 4) whether children improve in the daily living skills. OT4ASD follows a systematic protocol and uses active, individually-tailored sensory motor activities that are specifically designed to address the child's needs. The investigators believe this will be the first telehealth manualized protocol to address the sensory motor symptoms of ASD and measure outcomes at the daily life activity and participation levels.

Official Title

Testing the Feasibility of a Teletherapy Plus Parent Coaching Intervention for Children With Autism

Quick Facts

Study Start:2023-03-01
Study Completion:2024-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04832152

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:4 Years to 12 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of Autism Spectrum Disorder
  2. * Between the ages of 4 years 0 months and 12 years 0 months
  3. * Evidence of sensory symptoms based on the Sensory Processing Measure
  4. * Family is willing to participate
  5. * Physically able to participate in active, sensorimotor activities
  1. * Primary (visual or auditory) uncorrected sensory deficits
  2. * Do not meet age or diagnostic criteria

Contacts and Locations

Study Contact

Roseann C Schaaf, PhD
CONTACT
6102912179
roseann.schaaf@jefferson.edu
Rachel L Dumont, M.S.
CONTACT
6107641035
rachel.dumont@jefferson.edu

Study Locations (Sites)

Rose R. Kennedy Children's Evaluation and Rehabilitation Center (CERC) at Montefiore
Bronx, New York, 10461
United States

Collaborators and Investigators

Sponsor: Thomas Jefferson University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-03-01
Study Completion Date2024-06-30

Study Record Updates

Study Start Date2023-03-01
Study Completion Date2024-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Autism Spectrum Disorder